Bacterial pneumonia as an influenza complication
Ignacio Martin-Loeches1, Frank van Someren Gréve, Marcus J Schultz
1aMultidisciplinary Intensive Care Research Organization (MICRO) bDepartment of Clinical Medicine, Trinity Centre for Health Sciences, Trinity College Dublin (TCD), St James's University Hospitals, Dublin, Ireland cDepartment of Intensive Care dDepartment of Medical Microbiology eLaboratory of Experimental Intensive Care and Anesthesiology (LEICA), Academic Medical Center, Amsterdam, the Netherlands.
Bacterial coinfection is a frequent complication of influenza, especially in critically ill patients. Streptococcus pneumoniae is the most common pathogen, and evolving resistance patterns require attention during current outbreaks.
Area of Science:
- Infectious Diseases
- Immunology
- Epidemiology
Background:
- Influenza coinfection, particularly bacterial coinfection, pathogenesis and impact remain incompletely understood.
- Bacterial pneumonia is a significant complication of influenza virus infection.
- Understanding coinfection dynamics is crucial for managing influenza outbreaks.
Purpose of the Study:
- To review and summarize studies on bacterial coinfection during recent pandemic influenza outbreaks.
- To elucidate the role of systemic immune mechanisms in influenza-bacterial coinfection.
- To analyze the changing epidemiology of coinfection over time.
Main Methods:
- Literature review of studies on bacterial coinfection in influenza.
- Analysis of point prevalence data for bacterial coinfection in influenza patients.
- Examination of pathogen frequency and antimicrobial resistance trends.
Main Results:
- Bacterial coinfection is frequent, particularly in critically ill influenza patients.
- Streptococcus pneumoniae is the most common bacterial pathogen identified.
- Increasing rates of potentially resistant pathogens have been observed over the years.
- Systemic immune mechanisms are key to coinfection development.
Conclusions:
- Bacterial pneumonia is a confirmed influenza complication.
- Recent epidemiological findings clarify pathogen contributions to coinfection.
- Immunosuppression is a risk factor for bacterial coinfection in influenza.
- Evolving coinfection epidemiology necessitates updated management strategies for current outbreaks.
More Related Videos
10:47Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice
Published on: April 14, 2011
13:45A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia
Published on: September 21, 2019
Related Concept Videos
01:30Pneumonia III: Complications and Assessment
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pneumonia II: Pathophysiology
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: